Silencing of fat-1 transgene expression in sheep may result from hypermethylation of its driven cytomegalovirus (CMV) promoter

Theriogenology

Volumn 78, Issue 4, 2012, Pages 793-802

  Duan, B ^a   Cheng, L ^a   Gao, Y ^a   Yin, F X ^a   Su, G H ^a   Shen, Q Y ^a   Liu, K ^a   Hu, X ^a   Liu, X ^a   Li, G P ^a  

^a INNER MONGOLIA UNIVERSITY   (China)

Author keywords

CAG promoter; CMV promoter; Fat 1; Methylation; Somatic cell nuclear transfer; Transgenic

Indexed keywords

ACYL COENZYME A DESATURASE; CAENORHABDITIS ELEGANS PROTEIN; FAT 1 PROTEIN, C ELEGANS; FAT-1 PROTEIN, C ELEGANS;

ANIMAL; ANIMAL DISEASE; ARTICLE; CAENORHABDITIS ELEGANS; CELL CULTURE; CHICKEN; CLONING; CYTOMEGALOVIRUS; DNA METHYLATION; EVALUATION; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; METABOLISM; METHODOLOGY; NEWBORN; PHYSIOLOGY; PREGNANCY; PROMOTER REGION; SHEEP; TRANSGENE; TRANSGENIC ANIMAL; UPREGULATION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANIMALS, NEWBORN; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; CELLS, CULTURED; CHICKENS; CLONING, ORGANISM; CYTOMEGALOVIRUS; DNA METHYLATION; FATTY ACID DESATURASES; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE SILENCING; PREGNANCY; PROMOTER REGIONS, GENETIC; SHEEP; TRANSGENES; UP-REGULATION;

CAENORHABDITIS ELEGANS; CYTOMEGALOVIRUS; NEMATODA; OVIS ARIES; SIMIAN VIRUS 40;

EID: 84864330976     PISSN: 0093691X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.theriogenology.2012.03.027     Document Type: Article

References (37)

1. Kris-Etherton P.M., Hecker K.D., Binkoski A.E. Polyunsaturated fatty acids and cardiovascular health. Nutr Rev 2004, 62:414-426.
2. Gaibazzi N., Ziacchi V. Reversibility of stress-echo induced ST-segment depression by long-term oral n-3 PUFAs supplementation in subjects with chest pain syndrome, normal wall motion at stress-echo and normal coronary angiogram. BMC Cardiovasc Disord 2004, 4:312-316.
3. Mozaffarian D., Ascherio A., Hu F.B., Stampfer M.J., Willett W.C., Siscovick D.S., et al. Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men. Circulation 2005, 111:157-164.
4. Giamarellos-Bourboulis E.J., Mouktaroudi M., Adamis T., Koussoulas V., Baziaka F., Perrea D., et al. n-6 polyunsaturated fatty acids enhance the activities of ceftazidime and amikacin in experimental sepsis caused by multidrug-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 2004, 48:4713-4717.
5. Horrocks L.A., Yeo Y.K. Health benefits of docosahexaenoic acid (DHA). Pharmacol Res 1999, 40:211-225.
6. Arterburn L.M., Hall E.B., Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr 2006, 83:1467S-1476S.
7. Morgan C.A., Noble R.C., Cocchi M., McCartney R. Manipulation of the fatty acid composition of pig meat lipids by dietary means. J Sci Food Agric 1992, 58:357-368.
8. Wood J.D., Enser M. Factors influencing fatty acids in meat and the role of antioxidants in improving meat quality. Br J Nutr 1997, 78:S49-S60.
9. Spychalla J.P., Kinney A.J., Browse J. Identification of an animal omega-3 fatty acid desaturase by heterologous expression in Arabidopsis. Proc Natl Acad Sci U S A 1997, 94:1142-1147.
10. Kang J.X., Wang J., Wu L., Kang Z.B. Transgenic mice: fat-1 mice convert n-6 to n-3 fatty acids. Nature 2004, 427:504.
11. Zhu G., Chen H., Wu X., Zhou Y., Lu J., Chen H., et al. A modified n-3 fatty acid desaturase gene from Caenorhabditis briggsae produced high proportion of DHA and DPA in transgenic mice. Transgenic Res 2008, 17:717-725.
12. Lai L., Kang J.X., Li R., Wang J., Witt W.T., Yong H.Y., et al. Generation of cloned transgenic pigs rich in omega-3 fatty acids. Nat Biotechnol 2006, 24:435-436.
13. Saeki K., Matsumoto K., Kinoshita M., Suzuki I., Tasaka Y., Kano K., et al. Functional expression of a Delta12 fatty acid desaturase gene from spinach in transgenic pigs. Proc Natl Acad Sci U S A 2004, 101:6361-6366.
14. Xue L., Cheng L., Su G., Kang F., Wu X., Bai C., et al. Nuclear transfer procedures in the ovine can induce early embryo fragmentation and compromise cloned embryo development. Anim Reprod Sci 2011, 126:179-186.
15. Li G.P., White K.L., Bunch T.D. Review of enucleation methods and procedures used in animal cloning: state of the art. Cloning Stem Cells 2004, 6:5-13.
16. Wang S., Liu Y., Holyoak G.R., Evans R.C., Bunch T.D. A protocol for in vitro maturation and fertilization of sheep oocytes. Small Rumin Res 1998, 29:83-88.
17. Ge Y., Chen Z., Kang Z.B., Cluette-Brown J., Laposata M., Kang J.X. Effects of adenoviral gene transfer of C. elegans n-3 fatty acid desaturase on the lipid profile and growth of human breast cancer cells. Anticancer Res 2002, 22:537-544.
18. Lau B.Y., Ward W.E., Kang J.X., Ma D.W. Vertebrae of developing fat-1 mice have greater strength and lower n-6/n-3 fatty acid ratio. Exp Biol Med 2009, 234:632-638.
19. Li R., Lai L., Wax D., Hao Y., Murphy C.N., Rieke A., et al. Cloned transgenic swine via in vitro production and cryopreservation. Biol Reprod 2006, 75:226-230.
20. Van den Pol A.N., Ghosh P.K. Selective neuronal expression of green fluorescent protein with cytomegalovirus promoter reveals entire neuronal arbor in transgenic mice. J Neurosci 1998, 18:10640-10651.
21. Wakula P., Bisping E., Kockskämper J., Post H., Brauer S., Deuter M., et al. CMV promoter is inadequate for expression of mutant human RyR2 in transgenic rabbits. J Pharmacol Toxicol Methods 2010, 63:180-185.
22. George C.H., Higgs G.V., Lai F.A. Ryanodine receptor mutations associated with stress-induced ventricular tachycardia mediate increased calcium release in stimulated cardiomyocytes. Circ Res 2003, 93:531-540.
23. Furth P.A., Hennighausen L., Baker C., Beatty B., Woychick R. The variability in activity of the universally expressed human cytomegalovirus immediate early gene 1 enhancer/promoter in transgenic mice. Nucleic Acids Res 1991, 19:6205-6208.
24. Schmidt E.V., Christoph G., Zeller R., Leder P. The cytomegalovirus enhancer: A pan-active control element in transgenic mice. Mol Cell Biol 1990, 10:4406-4411.
25. Kong Q., Wu M., Huan Y., Zhang L., Liu H., Bou G., et al. Transgene expression is associated with copy number and cytomegalovirus promoter methylation in transgenic pigs. PLoS ONE 2009, 4:e6679.
26. Villuendas G., Gutiérrez-Adán A., Jiménez A., Rojo C., Roldán E.R., Pintado B. CMV-driven expression of green fluorescent protein (GFP) in male germ cells of transgenic mice and its effect on fertility. Int J Androl 2001, 24:300-305.
27. Dyck M.K., Ouellet M., Gagn M., Petitclerc D., Sirard M.A., Pothier F. Testes-specific transgene expression in insulin-like growth factor-I transgenic mice. Mol Reprod Dev 1999, 54:32-42.
28. Santos R.A., Ferreira A.J., Nadu A.P., Braga A.N., de Almeida A.P., Campagnole-Santos M.J., et al. Expression of an angiotensin-(1-7)-producing fusion protein produces cardioprotective effects in rats. Physiol Genomics 2004, 17:292-299.
29. Zhan Y., Brady J.L., Johnston A.M., Lew A.M. Predominant transgene expression in exocrine pancreas directed by the CMV promoter. DNA Cell Biol 2000, 19:639-645.
30. Yang P., Wang J., Gong G., Sun X., Zhang R., Du Z., et al. Cattle mammary bioreactor generated by a novel procedure of transgenic cloning for large-scale production of functional human lactoferrin. PLoS ONE 2008, 3:e3453.
31. Wu X., Ouyang H., Duan B., Pang D., Zhang L., Yuan T., et al. Production of cloned transgenic cow expressing omega-3 fatty acids. Transgenic Res 2011, [Epub ahead of print].
32. Mehta A.K., Majumdar S.S., Alam P., Gulati N., Brahmachari V. Epigenetic regulation of cytomegalovirus major immediate-early promoter activity in transgenic mice. Gene 2009, 428:20-24.
33. Kues W.A., Schwinzer R., Wirth D., Verhoeyen E., Lemme E., Herrmann D., et al. Epigenetic silencing and tissue independent expression of a novel tetracycline inducible system in double-transgenic pigs. FASEB J 2006, 20:1200-1202.
34. Tasic B., Hippenmeyer S., Wang C., Gamboa M., Zong H., Chen-Tsai Y., et al. Site-specific integrase-mediated transgenesis in mice via pronuclear injection. Proc Natl Acad Sci U S A 2011, 108:7902-7907.
35. Müller U., Doerfler W. Fixation of the unmethylated or the 5. J Virol 1987, 61:3710-3720.
36. Toth M., Lichtenberg U., Doerfler W. Genomic sequencing reveals a 5-methylcytosine-free domain in active promoters and the spreading of preimposed methylation patterns. Proc Natl Acad Sci U S A 1989, 86:3728-3732.
37. Grassi G., Maccaroni P., Meyer R., Kaiser H., D'Ambrosio E., Pascale E., et al. Inhibitors of DNA methylation and histone deacetylation activate cytomegalovirus promoter-controlled reporter gene expression in human glioblastoma cell line U87. Carcinogenesis 2003, 24:1625-1635.